25 related news articles for Stomach cancer

Hudson Institute researchers have had some great success in the recent NHMRC Grant rounds.…  Read more

H. pylori – short for Helicobacter pylori – colonises the stomach and is known to be linked to the development of stomach cancer. It is estimated that over half of the world’s population is infected with H. pylori, making it one of the most common bacterial infections.…  Read more

Despite encountering more than her share of health challenges, 92-year-old Delva Walker has the most positive outlook you are ever likely to encounter.…  Read more

As in so many cases, a tragic bereavement – the death of her husband from stomach cancer – was the catalyst for Janine’s decision to donate to medical research.…  Read more

The search for new therapies to treat a rare type of non-Hodgkins lymphoma has had an unexpected success – identifying a potential molecular target to treat other related forms of lymphoma as well.…  Read more

If an army marches on its stomach, as the old saying goes, then the US Department of Defense (DoD) is investing wisely in Australian upper gastrointestinal cancer research.…  Read more

Researchers aim to beat cancer at its own game by identifying modulators of the innate immune system that drive it and applying the brakes before cancer takes hold.…  Read more

Researchers in Melbourne have uncovered a stomach cancer trigger, providing vital clues to the origins of the world’s third-most-common cancer.…  Read more

A bacterium present in half the world’s population, Helicobacter pylori  is the target of new research aiming to develop a vaccine against stomach cancer.  …  Read more

Hudson Institute has again been recognised in the awarding of NHMRC Ideas Grants. These grants support innovative and creative research and build on Australia’s strong skills and international reputation in advanced health and medical research.…  Read more

A study on how genes of the immune system influence the development of gastric (stomach) cancer has identified a key contributor, offering the potential for better prognosis and treatment of this deadly disease.…  Read more

Researchers have identified a protein in immune cells that may play a role in thwarting a type of stomach cancer, paving the way for possible prevention therapies.…  Read more

We are pleased to announce that the inaugural recipient of the Daniel Wilson Memorial PhD Scholarship is Alice West—who, thanks to tremendous fundraising efforts, will have her research costs fully covered over the entirety of her 3–4-year study in stomach cancer.…  Read more

Improved treatments for a range of cancers could be possible following a discovery that stomach cancer is mainly driven by a different process than previously believed.…  Read more

Hudson Institute is delighted to announce the success of our researchers in the new NHMRC Investigator Grant round.…  Read more

Professor Brendan Jenkins took part in two Metafit (high intensity interval training) sessions last weekend, including one organised in Fairfield for coaches.

These sessions were held in memory of the late fitness trainer, Daniel Wilson to raise funds for a new scholarship at Hudson Institute.…  Read more

A leading Australian fitness coach, Daniel Wilson, died in May 2019 two months after being diagnosed with stomach cancer aged just 37. Daniel was well known for introducing Metafit, a HIIT (High Intensity Interval Training) program, to Australia.

Now, those who loved Daniel are commemorating his life by raising funds for medical research that will help find earlier diagnoses and treatments for others with stomach cancer.…  Read more

Pioneering Australian clinicians, Barry Marshall and Robin Warren first reported in 1982 that the stomach bacterium, Helicobacter pylori (H.plylori) causes gastritis and is a major risk factor in peptic ulcer disease and stomach cancer. Marshall and Warren were awarded the Nobel Prize in Physiology or Medicine in 2005 for their discovery, which has resulted in…  Read more

‘Clusters’ of immune cells are associated with advanced stomach cancers, but they provide few clinical or prognostic clues for these tumours, a new Hudson Institute study has found. Professor Brendan Jenkins, the study’s co-author, says that in some other cancers, the presence of these clusters, called immune cell aggregates, indicates improved patient survival – but…  Read more

New research from Hudson Institute of Medical Research is showing how a pro-inflammatory protein could offer new hope for stomach cancer treatment. A study, led by Dr Virginie Deswaerte and Professor Brendan Jenkins, found that modifying key components of the inflammatory response in the body could help to prevent tumour growth. The findings have been…  Read more

Scientists at Hudson Institute of Medical Research have identified a family of genes that could more accurately detect stomach cancer in its early stages to help improve survival rates. Stomach or gastric cancer is the third leading cause of cancer death worldwide. It is caused by the abnormal growth of cells in the lining, or…  Read more

Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

Why does a common bug, Helicobacter pylori, which is present in the stomachs of around half the world’s population, drive stomach cancer in some people? Associate Professor Richard Ferrero will establish how this seemingly innocuous bacterium drives growth of a specific type of stomach tumour, thanks to generous funding from the US Department of Defense.…  Read more

The gut microbiome, the vast ecosystem of bacteria that live within our digestive system, is becoming increasingly recognised for its essential role in supporting our physical and mental health.…  Read more

researcher in the current climate, but to also be a recipient of an inaugural veski inspiring women fellowship, is an outstanding achievement for Hudson Institute of Medical Research’s Dr Maria Kaparakis-Liaskos. Dr Liaskos, who works within the Institute’s Centre for Innate Immunity and Infectious Diseases, submitted her grant application shortly before commencing maternity leave.…  Read more